4
Changes in Ownership
Outlook Therapeutics, Inc. Filed Acc 0001209191-18-064382
Options or other derivatives
- Director acquired 1,505 shares (other)
From the SEC's structured data for this filing
Trades in this filing
BioLexis Pte Ltd. · Director
Table II: Derivative
1 line| Date | Transaction | Shares | Underlying | Owned after | D/I |
|---|---|---|---|---|---|
| 2018-12-31 | Other acquisition : show line 1 in the form Series A-1 Convertible Preferred Stock | +1,505 | 227,531 | 61,708 | D |
Loading xslF345X03/doc4.xml…